Menopauseal hormonal therapy and the risk of breast cancer in the light of new data

Menopause is a natural and inevitable physiological process of the decline reproductive function due to decrease in ovarian function, which every woman has face after about 45–60 years. During this period hormonal changes female body needs support more than ever, because quality life modern directly depends on it.The question menopausal hormone therapy (MHT) safety relation risk breast cancer perennial subject research, studied debated medical literature for 20 time, several different studies issue were conducted. In review we describe previous insights along with recent research using estradiol micronized progesterone MHT regimens. The evidence suggests that modifiable lifestyle factors (such as obesity alcohol consumption) rather combined are real risks; containing was not associated an increased cancer; when prescribing MHT, may be safer progestogen. clinical significance obtained results also discussed.